44 related articles for article (PubMed ID: 16386708)
1. Novel antagonists of heparin binding growth factors.
Cecchi F; Bottaro DP
Oncotarget; 2012 Sep; 3(9):911-2. PubMed ID: 22989865
[TBL] [Abstract][Full Text] [Related]
2. Enhanced secretion of biologically active, non-glycosylated VEGF from Saccharomyces cerevisiae.
Kang WK; Lee MH; Kim YH; Kim MY; Kim JY
J Biotechnol; 2013 Apr; 164(4):441-8. PubMed ID: 23422691
[TBL] [Abstract][Full Text] [Related]
3. Long-term reversal of diabetes by subcutaneous transplantation of pancreatic islet cells and adipose-derived stem cell sheet using surface-immobilized heparin and engineered collagen scaffold.
Kim YH; Ko JH; Lee S; Oh JY; Jeong GS; Park SN; Shim IK; Kim SC
BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32565421
[TBL] [Abstract][Full Text] [Related]
4. Oncofetal Chondroitin Sulfate: A Putative Therapeutic Target in Adult and Pediatric Solid Tumors.
Khazamipour N; Al-Nakouzi N; Oo HZ; Ørum-Madsen M; Steino A; Sorensen PH; Daugaard M
Cells; 2020 Mar; 9(4):. PubMed ID: 32231047
[TBL] [Abstract][Full Text] [Related]
5. Multiple cargo deliveries of growth factors and antimicrobial peptide using biodegradable nanopolymer as a potential wound healing system.
Vijayan A; James PP; Nanditha CK; Kumar GSV
Int J Nanomedicine; 2019; 14():2253-2263. PubMed ID: 30992665
[TBL] [Abstract][Full Text] [Related]
6. Improved recovery from limb ischaemia by delivery of an affinity-isolated heparan sulphate.
Poon S; Lu X; Smith RAA; Ho P; Bhakoo K; Nurcombe V; Cool SM
Angiogenesis; 2018 Nov; 21(4):777-791. PubMed ID: 29777314
[TBL] [Abstract][Full Text] [Related]
7. Contrasting biofunctionalization strategies for the enhanced endothelialization of biodegradable vascular grafts.
Melchiorri AJ; Hibino N; Yi T; Lee YU; Sugiura T; Tara S; Shinoka T; Breuer C; Fisher JP
Biomacromolecules; 2015 Feb; 16(2):437-46. PubMed ID: 25545620
[TBL] [Abstract][Full Text] [Related]
8. Regulation of vascular endothelial growth factor by metabolic context of the cell.
Kumar VB; Binu S; Soumya SJ; K H; Sudhakaran PR
Glycoconj J; 2014 Oct; 31(6-7):427-34. PubMed ID: 25214198
[TBL] [Abstract][Full Text] [Related]
9. Enhancing angiogenesis alleviates hypoxia and improves engraftment of enteric cells in polycaprolactone scaffolds.
Singh S; Wu BM; Dunn JC
J Tissue Eng Regen Med; 2013 Dec; 7(12):925-33. PubMed ID: 22511397
[TBL] [Abstract][Full Text] [Related]
10. Binding of ATP to vascular endothelial growth factor isoform VEGF-A165 is essential for inducing proliferation of human umbilical vein endothelial cells.
Gast RE; König S; Rose K; Ferenz KB; Krieglstein J
BMC Biochem; 2011 May; 12():28. PubMed ID: 21619628
[TBL] [Abstract][Full Text] [Related]
11. The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin.
Singh S; Wu BM; Dunn JC
Biomaterials; 2011 Mar; 32(8):2059-69. PubMed ID: 21147501
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of rhVEGF release from topical hydrogel formulations.
Ji JA; Liu J; Shire SJ; Kamerzell TJ; Hong S; Billeci K; Shen Y; Wang YJ
Pharm Res; 2010 Apr; 27(4):644-54. PubMed ID: 20155389
[TBL] [Abstract][Full Text] [Related]
13. Persistent inflammation and angiogenesis during wound healing in K14-directed Hoxb13 transgenic mice.
Mack JA; Maytin EV
J Invest Dermatol; 2010 Mar; 130(3):856-65. PubMed ID: 19759546
[TBL] [Abstract][Full Text] [Related]
14. Reduced vascular endothelial growth factor expression in contusive spinal cord injury.
Herrera JJ; Nesic O; Narayana PA
J Neurotrauma; 2009 Jul; 26(7):995-1003. PubMed ID: 19257807
[TBL] [Abstract][Full Text] [Related]
15. Neurons produce FGF2 and VEGF and secrete them at least in part by shedding extracellular vesicles.
Schiera G; Proia P; Alberti C; Mineo M; Savettieri G; Di Liegro I
J Cell Mol Med; 2007; 11(6):1384-94. PubMed ID: 18205708
[TBL] [Abstract][Full Text] [Related]
16. Investigating the effect of VEGF glycosylation on glycosaminoglycan binding and protein unfolding.
Brandner B; Kurkela R; Vihko P; Kungl AJ
Biochem Biophys Res Commun; 2006 Feb; 340(3):836-9. PubMed ID: 16386708
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
[TBL] [Abstract][Full Text] [Related]
18. Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites.
Mitsi M; Hong Z; Costello CE; Nugent MA
Biochemistry; 2006 Aug; 45(34):10319-28. PubMed ID: 16922507
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin X binds to cell surface heparan sulfate proteoglycans.
Nascimento FD; Rizzi CC; Nantes IL; Stefe I; Turk B; Carmona AK; Nader HB; Juliano L; Tersariol IL
Arch Biochem Biophys; 2005 Apr; 436(2):323-32. PubMed ID: 15797245
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
